MedElevator Войти в исследования
← Поиск публикаций

DOI 10.64898/2026.06.06.26354927

Медицинская библиотека · medRxiv : the preprint server for health sciences · 2026

Association of Genetic Liability to Psychiatric Disorders with Peripheral Metabolic Dysregulation.

De la Hoz Juan F, Lee Younga Heather, Tubbs Justin D, Meyerson William, Cudic Mihael, Watts Devon, Feng Yen-Chen Anne, Chen Yulu, Lasky-Su Jessica, Ge Tian, Smoller Jordan W

СтатьяПрепринтПеревод в очереди

Аннотация

IMPORTANCE

Individuals with psychiatric disorders face elevated cardiometabolic risk which is linked to increased mortality. The extent to which this reflects shared pathogenesis or the downstream effects of illness and treatment remains poorly understood.

OBJECTIVE

To characterize the direct pleiotropic effects of psychiatric genetic liability on circulating metabolites and aggregate cardiometabolic risk, independent of psychiatric diagnosis and psychotropic medication use.

DESIGN SETTING AND

PARTICIPANTS

Cross-sectional analysis of Mass General Brigham Biobank participants with metabolomic profiling, genomic data, and linked electronic health records.

EXPOSURES: Genetic liability to nine psychiatric disorders quantified using polygenic risk scores (PRS): attention deficit/hyperactivity disorder (ADHD), anorexia nervosa (ANO), anxiety disorder (ANX), autism spectrum disorder (ASD), bipolar disorder (BD), major depressive disorder (MDD), PTSD, schizophrenia (SCZ), and substance use disorder (SUD).

MAIN OUTCOMES AND MEASURES: 249 circulating metabolites and four metabolomic risk scores (MRS) for type 2 diabetes, myocardial infarction, ischemic stroke, and vascular dementia. PRS-metabolite associations were estimated using nested models adjusting for lifetime psychiatric diagnosis and psychotropic medication use.

RESULTS

Across 25,290 participants, we identified 604 significant PRS-metabolite associations (Bonferroni p< 1.36 x 10-4), of which 89% persisted after adjustment for lifetime diagnosis and medication use, suggesting that the direct genetic effects on metabolism are largely independent of illness or treatment. PRS for MDD, PTSD, and ADHD showed the most extensive dysregulation, with a transdiagnostic pattern of elevated lipids and systemic inflammation, specifically triglycerides (β = 0.04 to 0.05, all p< 4.4 x10-13) and glycoprotein acetyls (β = 0.05, all p< 2.2 x10-16). Notably, PRS for SCZ and BD showed minimal metabolite dysregulation despite having the strongest association with their target diagnoses. PRS for MDD, PTSD, ADHD, and SUD were associated with increased MRS across cardiometabolic conditions (β = 0.03 to 0.08, all p< 2.1 x10-4). Sensitivity analyses controlling for BMI or excluding participants without any psychiatric history (N: 21,305 and 11,150, respectively) showed a similar pattern.

CONCLUSIONS AND RELEVANCE: Psychiatric genetic liability is associated with systemic metabolic dysregulation independent of illness onset or treatment, supporting a partially pleiotropic basis for psychiatric-cardiometabolic comorbidity.

Для цитирования: De la Hoz Juan F, Lee Younga Heather, Tubbs Justin D, Meyerson William, Cudic Mihael, Watts Devon, Feng Yen-Chen Anne, Chen Yulu, Lasky-Su Jessica, Ge Tian, Smoller Jordan W. Association of Genetic Liability to Psychiatric Disorders with Peripheral Metabolic Dysregulation.. medRxiv : the preprint server for health sciences. 2026. DOI: 10.64898/2026.06.06.26354927.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.